A single dose of a monoclonal antibody developed by scientists at the US National Institutes of Health (NIH) has provided protection for people exposed to malaria parasites for up to nine months.

Writing in Cell Reports, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators have presented a multifaceted analysis and structure-function study of a ...

Mar. 5, 2025 — Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers discovered a key process where malarial parasites take ...

In the interim, a strategy using antibody-containing mosquito baits that mosquitoes can feed on might prove effective. The study was published online in Nature Microbiology on March 6. “This study ...

Firstly, they immunize rabbits and mice with some of the malaria proteins to look at what antibodies — the immune proteins that identify and bind to threats in the body — the rabbit and mice ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).